Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 5/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | MME | P08473 | 2/20 | 0.31 |
| ▸ | ACE | P12821 | 2/20 | 0.31 |
| ▸ | CPA1 | P15085 | 2/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.31 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3977092 | 0.90 | CA1 (0.39) | CA1CA2CA7CA14DPP4 | |
| SCHEMBL18826564 | 0.87 | CA1 (0.40) | CA1CA2CA7CA14DPP4 | |
| SCHEMBL29170630 | 0.81 | SLC7A5 (0.36) | ALDH1A1 | |
| SCHEMBL23559935 | 0.78 | ENPEP (0.34) | ENPEPTSHR | |
| SCHEMBL25853900 | 0.78 | ECE1 (0.36) | — | |
| SCHEMBL82496 | 0.78 | SLC7A5 (0.38) | ALDH1A1EPHX1 | |
| SCHEMBL27806633 | 0.78 | SLC7A5 (0.38) | ALDH1A1EPHX1 | |
| SCHEMBL3499612 | 0.77 | ALDH1A1 (0.42) | CA1CA2CA7CA14ALDH1A1 | |
| SCHEMBL20489982 | 0.77 | CA1 (0.38) | CA1CA2CA7CA14DPP4 | |
| SCHEMBL13311446 | 0.77 | ALDH1A1 (0.42) | CA1CA2CA7CA14ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190125701-A1 | Compositions and Methods for Treating Viral Infection in Mammals | UNIV YALE (US) | 2019-05-02 | — | — | US | claimed |
| EP-3452172-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION IN MAMMALS | Yale University (US) | 2019-03-13 | — | — | EP | claimed |
| WO-2017192799-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION IN MAMMALS | YALE UNIVERSITY (US) | 2017-11-09 | — | — | WO | claimed |
| EP-1761238-A1 | MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION COMPRISING THE SAME | Takasago International Corporation (JP) | 2007-03-14 | — | — | EP | claimed |
| WO-2005115325-A1 | MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION COMPRISING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-12-08 | — | — | WO | claimed |
| WO-2021195183-A1 | COMPOSITIONS AND METHODS FOR INHIBITING PROTEIN EMBRYONIC ECTODERM DEVELOPMENT ACTIVITY AND TREATING DISEASE | EXO THERAPEUTICS, INC. (US) | 2021-09-30 | — | — | WO | disclosed |
| US-20190125701-A1 | Compositions and Methods for Treating Viral Infection in Mammals | UNIV YALE (US) | 2019-05-02 | — | — | US | disclosed |
| US-20190125701-A1 | Compositions and Methods for Treating Viral Infection in Mammals | UNIV YALE (US) | 2019-05-02 | — | — | US | disclosed |
| EP-3452172-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION IN MAMMALS | Yale University (US) | 2019-03-13 | — | — | EP | disclosed |
| WO-2017192799-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION IN MAMMALS | YALE UNIVERSITY (US) | 2017-11-09 | — | — | WO | disclosed |
| US-20160282672-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2016-09-29 | — | — | US | disclosed |
| EP-2262534-A1 | PALATABLE SOLID COMPOSITION COMPRISING ANTACID AND SALIVA STIMULANT | Bayer Consumer Care AG (CH) | 2010-12-22 | — | — | EP | disclosed |
| WO-2009123355-A2 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-08 | — | — | WO | disclosed |
| WO-2009112156-A1 | PALATABLE SOLID COMPOSITION COMPRISING ANTACID AND SALIVA STIMULANT | BAYER CONSUMER CARE AG (CH) | 2009-09-17 | — | — | WO | disclosed |
| EP-1902043-A1 | VANILLIN ACETALS AND SENSORY STIMULANT COMPOSITION CONTAINING THE SAME | Takasago International Corporation (JP) | 2008-03-26 | — | — | EP | disclosed |
| EP-1761238-A1 | MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION COMPRISING THE SAME | Takasago International Corporation (JP) | 2007-03-14 | — | — | EP | disclosed |
| WO-2007004740-A1 | VANILLIN ACETALS AND SENSORY STIMULANT COMPOSITION CONTAINING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-01-11 | — | — | WO | disclosed |
| WO-2005115325-A1 | MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION COMPRISING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190125701-A1 | Compositions and Methods for Treating Viral Infection in Mammals | RPL35, PIGS, HAVCR2 | CA1 334/4885CA2 718/4885CA7 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.